Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Pulmonary Hypertension

Free Subscription 16.03.2026 1 Adv Ther 1 Am Heart J 1 Am J Cardiol 1 Am J Med Genet A 1 Am J Physiol Lung Cell Mol Physiol 1 Am J Respir Crit Care Med 1 Arterioscler Thromb Vasc Biol 3 Biomed Pharmacother 1 BMC Med Imaging 1 BMJ Open 1 Br J Biomed Sci 1 Cardiovasc Drugs Ther 1 Cardiovasc J Afr 1 Catheter Cardiovasc Interv 6 Chest 1 Circ Rep 1 Circ Res 1 Clin Chim Acta 1 Clin Sci (Lond) 1 Comput Methods Biomech Biomed Engin 1 Cureus 1 Curr Opin Crit Care 1 Egypt Heart J 1 ERJ Open Res 1 ESC Heart Fail 1 Eur Heart J 1 Eur Heart J Case Rep 1 Eur J Pediatr Surg 1 Eur Respir J 1 Eur Respir Rev 1 Eye (Lond) 1 Food Funct 3 Free Radic Biol Med 1 Front Cardiovasc Med 2 Front Med (Lausanne) 1 Front Pharmacol 1 Genomics 1 Geroscience 1 Hemasphere 1 Hypertens Res 1 Int Heart J 1 Int Immunopharmacol 1 Int J Cardiol Congenit Heart Dis 1 J Am Assoc Nurse Pract 1 J Am Coll Cardiol 1 J Am Heart Assoc 1 J Am Soc Echocardiogr 1 J Cardiol Cases 1 J Cardiothorac Vasc Anesth 1 J Heart Lung Transplant 1 J Med Case Rep 1 J Nucl Cardiol 1 J Pharmacol Sci 1 J Thorac Dis 1 JACC Cardiovasc Imaging 1 JCI Insight 1 Life Sci 1 Magn Reson Med 1 Neoreviews 1 NPJ Cardiovasc Health 1 Pain Manag 1 Pediatr Res 3 Physiol Rep 1 Physiol Res 2 PLoS One 6 Pulm Circ 1 Pulm Pharmacol Ther 1 Pulmonology 2 Respir Med 1 Respir Med Case Rep 1 Respir Res 1 Respirol Case Rep 1 Sci Prog 1 Ulus Travma Acil Cerrahi Derg 2 Vascul Pharmacol 2 Zhongguo Zhong Yao Za Zhi 3 Zhonghua Jie He He Hu Xi Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Ther

1. ZISMAN D, Sahay S, Bandyopadhyay D, Al-Astal A, et al
   Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER Study.
   Adv Ther. 2026 Mar 10. doi: 10.1007/s12325-026-03508.
   PubMed         Abstract available
   
   

   
   Am Heart J

2. CANTU-MARTINEZ O, Fudim M, Kong DF, Tedford RJ, et al
   Accuracy of site versus core laboratory interpretations of right heart catheterization hemodynamics.
   Am Heart J. 2026;295:107351.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

3. BAGGA A, Astavans A, Goldin G, Everitt IK, et al
   National Patterns of Pulmonary Hypertension Mortality in the United States, 2010-2024.
   Am J Cardiol. 2026 Mar 3:S0002-9149(26)00117.
   PubMed        
   
   

   
   Am J Med Genet A

4. TAKAI A, Yamagishi M, Ikeda K, Sugimoto A, et al
   Effectiveness of cardiac palliative surgery for trisomy 18 patients with increased pulmonary blood flow.
   Am J Med Genet A. 2023;191:2703-2710.
   PubMed         Abstract available
   
   

   
   Am J Physiol Lung Cell Mol Physiol

5. RICHALET JP, Jeny F, Callard P, Bernaudin JF, et al
   High-altitude pulmonary edema: the intercellular network hypothesis.
   Am J Physiol Lung Cell Mol Physiol. 2023;325:L155-L173.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

6. CHEN CN, Hajji N, Yeh FC, Rahman S, et al
   Restoration of Foxp3(+) Regulatory T Cells by HDAC-Dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology.
   Am J Respir Crit Care Med. 2023;208:879-895.
   PubMed         Abstract available
   
   

   
   Arterioscler Thromb Vasc Biol

7. WANG WT, Li X, Wang T, Ferrizzi SA, et al
   Pulmonary Vascular Signaling in Pulmonary Hypertension: Potential Role of Endothelial Ca(2+) Signaling in Cellular Senescence and Inflammasome Activation.
   Arterioscler Thromb Vasc Biol. 2026 Mar 12. doi: 10.1161/ATVBAHA.125.322489.
   PubMed         Abstract available
   
   

   
   Biomed Pharmacother

8. SHEN Z, Huang D, Jia N, Zhao S, et al
   Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosis.
   Biomed Pharmacother. 2023;167:115607.
   PubMed         Abstract available
   
   
9. YU Y, Wang Y, Yang Z, Li Z, et al
   Corrigendum to "Methyleugenol alleviates pulmonary vascular remodeling in rats with high-altitude pulmonary hypertension by improving pulmonary smooth muscle cell function" [Biomed. Pharmacother. 187 (2025) 118109].
   Biomed Pharmacother. 2026 Mar 11:119202. doi: 10.1016/j.biopha.2026.119202.
   PubMed        
   
   
10. VILLEGAS-ESGUEVILLAS M, Barreira B, Hernandez-Garcia A, Adao R, et al
    The Sigma-1 receptor agonist PRE084 improves cardiopulmonary function and remodelling in an experimental model of pulmonary arterial hypertension.
    Biomed Pharmacother. 2026;196:119115.
    PubMed         Abstract available
    
    

    
    BMC Med Imaging

11. CHENG Q, Yang F, Wu C, Xiao D, et al
    Machine learning-based predictive model for the diagnosis of PH pulmonary hypertension diagnosis integrating cardiac magnetic resonance imaging and clinical biomarkers.
    BMC Med Imaging. 2026 Mar 9. doi: 10.1186/s12880-026-02254.
    PubMed        
    
    

    
    BMJ Open

12. YOSHIDA K, Hosokawa K, Hiraide T, Akagi S, et al
    Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension a
    BMJ Open. 2026;16:e113430.
    PubMed         Abstract available
    
    

    
    Br J Biomed Sci

13. SUBRAMANIAM J, Jonnakuti V, Collum SD, Martineau S, et al
    Alternative Polyadenylation Signatures Distinguish Maladaptive Right Ventricular Remodeling in Pulmonary Hypertension: Implications for RNA-Based Diagnostics and Therapeutics.
    Br J Biomed Sci. 2026;83:15687.
    PubMed         Abstract available
    
    

    
    Cardiovasc Drugs Ther

14. CAO Z, Ma W, Liu C
    Hyperuricemia and Hypoxic Pulmonary Hypertension: Pathogenic Links, Clinical Evidence, and Emerging Therapeutic Insights.
    Cardiovasc Drugs Ther. 2026 Mar 6. doi: 10.1007/s10557-026-07859.
    PubMed         Abstract available
    
    

    
    Cardiovasc J Afr

15. OGUNTADE AS, Ogah OS, Adebiyi AA, Oladokun B, et al
    Right ventricular function, pulmonary hypertension and incident mortality in heart failure: Insights from a West-African cohort.
    Cardiovasc J Afr. 2025;36:309-322.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

16. SAGAR P, Thejaswi P, Karthikeyan M, Sivakumar K, et al
    Custom-Fenestrated Atrial Septal Occluder Devices in Borderline Patients With Pulmonary Arterial Hypertension or Restrictive Left Ventricular Physiology.
    Catheter Cardiovasc Interv. 2026;107:1156-1169.
    PubMed         Abstract available
    
    

    
    Chest

17. ROTER KW, Agrawal V
    Decoding Exercise Pulmonary Hypertension: A Noninvasive Blueprint for Detection in Chronic Thromboembolic Pulmonary Disease.
    Chest. 2026;169:584-585.
    PubMed        
    
    
18. JOHN T, Neuhuber L, Douschan P, Foris V, et al
    The Clinical Relevance of Unclassified Pulmonary Hypertension.
    Chest. 2026 Mar 9:S0012-3692(26)00275-8. doi: 10.1016/j.chest.2025.
    PubMed        
    
    
19. LAMMI MR, Khan SL, Rao Y, Zhao W, et al
    The Minimal Important Difference in N-Terminal Pro-Brain Natriuretic Peptide in Pulmonary Hypertension.
    Chest. 2026 Mar 7:S0012-3692(26)00287-4. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    
20. PRADHAN NM, Wessler BS, Hill N, Kurz S, et al
    The Mitral Valve and The Lungs.
    Chest. 2025 Nov 24:S0012-3692(25)05795-2. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available
    
    
21. BRONCANO J, Shifren A, Royuela J, Bhalla S, et al
    Role of MRI in Interstitial Lung Diseases.
    Chest. 2026;169:698-709.
    PubMed         Abstract available
    
    
22. WANG AY, Ma JL, Cui Y, Qiu BC, et al
    Growth Differentiation Factor-15 Improves Prognostic Accuracy of Risk Stratification in Pulmonary Arterial Hypertension.
    Chest. 2026;169:758-768.
    PubMed         Abstract available
    
    

    
    Circ Rep

23. HIROSE M, Nakano Y, Adachi S, Sugiyama T, et al
    Prevalence, Clinical Features, and Treatment Response of Chronic Thromboembolic Pulmonary Hypertension in Patients With Myeloproliferative Neoplasm.
    Circ Rep. 2025;8:486-494.
    PubMed         Abstract available
    
    

    
    Circ Res

24. JOKI Y, Konishi H, Takasu K, Katsuumi G, et al
    Parathyroid Hormone Contributes to Pulmonary Hypertension in Hypoxic Conditions.
    Circ Res. 2026 Mar 4. doi: 10.1161/CIRCRESAHA.125.327401.
    PubMed         Abstract available
    
    

    
    Clin Chim Acta

25. QIAN X, Deng Y, Guo T, Huang X, et al
    Plasma non-targeted metabolomics unveils the metabolic signatures of trans-right ventricle in pulmonary arterial hypertension associated with atrial septal defect.
    Clin Chim Acta. 2026;584:120849.
    PubMed         Abstract available
    
    

    
    Clin Sci (Lond)

26. SUZUKI Y, Ramadhiani R, Ryanto GRT, Musthafa A, et al
    Loss of Endothelin-2 in Pulmonary Neuroendocrine Cells Promotes the Development of Hypoxia-induced Pulmonary Hypertension.
    Clin Sci (Lond). 2026 Mar 3:CS20250135. doi: 10.1042/CS20250135.
    PubMed         Abstract available
    
    

    
    Comput Methods Biomech Biomed Engin

27. ZHAO D, Li Y, Yang Y, Yu F, et al
    An optimized machine learning model based on hematological indicators for the noninvasive identification of baicalin's therapeutic effects in pulmonary hypertension.
    Comput Methods Biomech Biomed Engin. 2026.
    PubMed         Abstract available
    
    

    
    Cureus

28. KEKEC L, Radisavljevic Vitas S, Bervar M, Taleska Stupica G, et al
    Perioperative Use of Pulmonary Artery Catheter in a Patient With Severe Chronic Thromboembolic Pulmonary Hypertension Undergoing Major Gynecological Surgery: A Case Report.
    Cureus. 2026;18:e103094.
    PubMed         Abstract available
    
    

    
    Curr Opin Crit Care

29. JOSE A, Elwing JM
    Management of hepatopulmonary syndrome and portopulmonary hypertension.
    Curr Opin Crit Care. 2026;32:187-192.
    PubMed         Abstract available
    
    

    
    Egypt Heart J

30. MULAWARMAN R, Ongko Joyo E, Aefiansyah Putra MA, Agita Sembiring A, et al
    Reversing the irreversible? A case of successful surgical repair in a late-presenting aortopulmonary window with severe pulmonary hypertension.
    Egypt Heart J. 2026;78:15.
    PubMed         Abstract available
    
    

    
    ERJ Open Res

31. HERTIG D, Furian M, Muller J, Mayer L, et al
    Effect of short-term supplemental oxygen therapy on 6-min walk distance in highlanders at risk for pulmonary hypertension: a randomised, crossover trial.
    ERJ Open Res. 2026;12:00724-2025.
    PubMed         Abstract available
    
    

    
    ESC Heart Fail

32. RICHTER MJ, Douschan P, Fortuni F, Gall H, et al
    Echocardiographic pressure-strain loop-derived stroke work of the right ventricle: validation against the gold standard.
    ESC Heart Fail. 2023;10:3209-3215.
    PubMed         Abstract available
    
    

    
    Eur Heart J

33. XU H, Ye L, Du C, Tang H, et al
    EP4/ANXA2 axis in pulmonary arterial hypertension: therapeutic implications.
    Eur Heart J. 2025 Sep 25:ehaf763. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur Heart J Case Rep

34. WANG E, Palaskas NL, Sahay S, Yu W, et al
    Tumoural emboli syndromes case series: diagnostic dilemma in patients with cancer and pulmonary hypertension.
    Eur Heart J Case Rep. 2026;10:ytag079.
    PubMed        
    
    

    
    Eur J Pediatr Surg

35. PEIXOTO J, Neto J, Pissarra S, Azevedo I, et al
    Giant Omphalocele: Systematic Review of Pulmonary Complications and Implications for Neonatal Care.
    Eur J Pediatr Surg. 2025 Jul 17. doi: 10.1055/a-2649-0781.
    PubMed         Abstract available
    
    

    
    Eur Respir J

36. RAGHU G, Sahay S, Price LC, Weatherald J, et al
    Pulmonary Hypertension Associated With Interstitial Lung Disease: State-of-the-Art Review.
    Eur Respir J. 2026 Mar 12:2502651. doi: 10.1183/13993003.02651-2025.
    PubMed         Abstract available
    
    

    
    Eur Respir Rev

37. JUTANT EM, Humbert M, Montani D, Khoury J, et al
    Pulmonary hypertension associated with nonparenchymal restrictive lung diseases.
    Eur Respir Rev. 2026;35:250187.
    PubMed         Abstract available
    
    

    
    Eye (Lond)

38. EILON E, Lishinsky-Fischer N, Levy J
    Response to: 'Comment on 'Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study".
    Eye (Lond). 2026 Mar 3. doi: 10.1038/s41433-026-04379.
    PubMed        
    
    

    
    Food Funct

39. ZHAO Q, Su S, Chen J, Huayu M, et al
    Kaempferol alleviates right ventricular hypertrophy in high-altitude pulmonary hypertension rats by modulating the AMPK/ACC/CPT1B axis and the AMPK-mediated LDHA/PDHA1 pathway.
    Food Funct. 2026 Mar 10. doi: 10.1039/d5fo04265.
    PubMed         Abstract available
    
    

    
    Free Radic Biol Med

40. GAO D, Song S, Gao Y, Zhu X, et al
    Silencer-regulated circLSM14A inhibits autophagy of pulmonary artery smooth muscle cells through parental protein LSM14A.
    Free Radic Biol Med. 2026;247:502-515.
    PubMed         Abstract available
    
    
41. JING H, Liu J, Guo Y, Gao Z, et al
    Smooth Muscle NR4A3 Upregulation Caused by Endothelial Caveolin-1 Deficiency Mediates Vascular Remodeling and Pulmonary Hypertension.
    Free Radic Biol Med. 2026 Mar 9:S0891-5849(26)00188.
    PubMed         Abstract available
    
    
42. LI L, Liu B, Zhang M, Wang D, et al
    TG2 (transglutaminase 2) promotes PINK1/Parkin-dependent mitophagy in pulmonary hypertension by regulating the TRPC6.
    Free Radic Biol Med. 2026 Mar 9:S0891-5849(26)00180.
    PubMed         Abstract available
    
    

    
    Front Cardiovasc Med

43. QIN X, Zheng L, Zhao H, Li Q, et al
    Identification of circulating microRNA biomarkers in pulmonary hypertension of group 2 for early detection.
    Front Cardiovasc Med. 2026;13:1704427.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

44. RUESS A, Stadler S, Stark T, Berezucki E, et al
    Hemodynamic effects of cycle ergometry and low-intensity handgrip in patients with pulmonary hypertension.
    Front Med (Lausanne). 2026;13:1727173.
    PubMed         Abstract available
    
    
45. WANG R, Tan J, Li G, Pan Z, et al
    Development and internal validation of a machine learning-based prediction model for pulmonary hypertension in COPD.
    Front Med (Lausanne). 2026;13:1752113.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

46. LIANG Q, Gou H, Zhu Y, He L, et al
    Inhibiting the pathological changes of PASMCs is an effective approach for medicinal plants or secondary metabolites in treating pulmonary hypertension.
    Front Pharmacol. 2026;17:1725809.
    PubMed         Abstract available
    
    

    
    Genomics

47. LI L, Xue Q, Zhang M, Yang Z, et al
    Upregulation of the key biomarker kinesin family member 20A (KIF20A) is associated with pulmonary artery hypertension.
    Genomics. 2023;115:110705.
    PubMed         Abstract available
    
    

    
    Geroscience

48. POLINI B, Ghelardoni S, Capone G, Monti E, et al
    Circulating microRNAs in pulmonary arterial hypertension: biomarkers for diagnosis, prognostic stratification, and treatment.
    Geroscience. 2026;48:2243-2266.
    PubMed         Abstract available
    
    

    
    Hemasphere

49. CENDALI FI, Lisk C, Argabright A, Dzieciatkowska M, et al
    Iron, arginine, and redox metabolism in peripheral blood mononuclear cells distinguishes sickle cell disease and pulmonary hypertension.
    Hemasphere. 2026;10:e70318.
    PubMed         Abstract available
    
    

    
    Hypertens Res

50. QIU LH, Wang PR, Zhang K, Ning XH, et al
    The application of partial pressure of oxygen adjusted indirect Fick method in vasoreactivity testing by inhaling oxygen in congenital heart disease.
    Hypertens Res. 2026;49:874-882.
    PubMed         Abstract available
    
    

    
    Int Heart J

51. TAMURA Y, Kumamaru H, Nishimura S, Nakajima Y, et al
    Initial Triple Combination Therapy Including Intravenous Prostaglandin I(2) for the Treatment of Patients with Severe Pulmonary Arterial Hypertension.
    Int Heart J. 2023;64:684-692.
    PubMed         Abstract available
    
    

    
    Int Immunopharmacol

52. CUI H, Min F, Deng H, Wang Y, et al
    Leonurine ameliorates hypoxic pulmonary hypertension by inhibiting cross-talk between neutropHils and endothelial cells via SERPINB3 targeting.
    Int Immunopharmacol. 2026;176:116467.
    PubMed         Abstract available
    
    

    
    Int J Cardiol Congenit Heart Dis

53. GIANNAKOULAS G, Preston IR, Gatzoulis MA
    Advancing the science and care of pulmonary hypertension, globally.
    Int J Cardiol Congenit Heart Dis. 2025;23:100651.
    PubMed        
    
    

    
    J Am Assoc Nurse Pract

54. RYAN JJ, Wilson M, Saggar R, Benninger C, et al
    Expert consensus on patient engagement strategies for improving patient activation and shared decision making in pulmonary arterial hypertension.
    J Am Assoc Nurse Pract. 2026;38:136-145.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

55. KHAN MS, Borlaug BA, Butler J, Gomberg-Maitland M, et al
    Pulmonary Hypertension Associated With Left Heart Disease: Challenges, Emerging Strategies, and Future Directions.
    J Am Coll Cardiol. 2026 Mar 11:S0735-1097(26)00134.
    PubMed         Abstract available
    
    

    
    J Am Heart Assoc

56. KHALIL F, Asleh R, Mawer S, Kim K, et al
    Interplay of Pulmonary Hypertension and the Effects of Panel-Reactive Antibodies on Outcomes of Heart Transplant Recipients Bridged With Left Ventricular Assist Device.
    J Am Heart Assoc. 2026 Mar 4:e044572. doi: 10.1161/JAHA.125.044572.
    PubMed         Abstract available
    
    

    
    J Am Soc Echocardiogr

57. WONG JM, Lai E, Brent BN, Schiller NB, et al
    Noninvasive Assessment of Mean Pulmonary Artery Pressure: A Comparison of Doppler Echocardiographic Methods.
    J Am Soc Echocardiogr. 2026;39:294-303.
    PubMed         Abstract available
    
    

    
    J Cardiol Cases

58. NOGUCHI Y, Miyake M, Mima H, Matsutani H, et al
    Usefulness of exercise stress echocardiography to identify masked pulmonary hypertension associated with hyperthyroidism.
    J Cardiol Cases. 2025;33:75-77.
    PubMed         Abstract available
    
    

    
    J Cardiothorac Vasc Anesth

59. SARDO S, Tripodi VF, Guerzoni F, Musu M, et al
    Pulmonary Vasodilator and Inodilator Drugs in Cardiac Surgery: A Systematic Review With Bayesian Network Meta-Analysis.
    J Cardiothorac Vasc Anesth. 2023;37:2261-2271.
    PubMed         Abstract available
    
    

    
    J Heart Lung Transplant

60. LUO D, Zheng X, Yang Z, Li H, et al
    Machine learning for clustering and postclosure outcome of adult CHD-PAH patients with borderline hemodynamics.
    J Heart Lung Transplant. 2023;42:1286-1297.
    PubMed         Abstract available
    
    

    
    J Med Case Rep

61. ANDRYAN DP, Hasanah DY, Atmadikoesoemah CA
    The potential effect of calcium sensitizer in pulmonary hypertension post-coronavirus disease-19 infection in presumptive familial dilated cardiomyopathy: a case report.
    J Med Case Rep. 2026 Mar 5. doi: 10.1186/s13256-026-05854.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

62. WERNER RA, Higuchi T
    In vivo targeting of fibroblast activation in chronic thromboembolic pulmonary hypertension: Ready for pulmonary prime time?
    J Nucl Cardiol. 2026;56:102588.
    PubMed        
    
    

    
    J Pharmacol Sci

63. FUJIWARA M, Yamamura A, Kondo R, Suzuki Y, et al
    Therapeutic effects of fingolimod through sphingosine-1-phosphate signaling in pulmonary arterial hypertension.
    J Pharmacol Sci. 2026;160:191-198.
    PubMed         Abstract available
    
    

    
    J Thorac Dis

64. ZHAO J, Li N, Shi S, Zhao Y, et al
    Chronic thromboembolic pulmonary hypertension: insights from the 100 most cited papers: a bibliometric perspective.
    J Thorac Dis. 2026;18:98.
    PubMed         Abstract available
    
    

    
    JACC Cardiovasc Imaging

65. CHEN HM, Hou P, Liang SH, Guo WL, et al
    The Prognostic Value of (18)F-FAPI PET/CT Imaging in Pulmonary Arterial Hypertension.
    JACC Cardiovasc Imaging. 2026;19:363-374.
    PubMed         Abstract available
    
    

    
    JCI Insight

66. BOLAND E, Freeman MG, Corcoran DS, Ford TJ, et al
    Coronary pathophysiology in idiopathic pulmonary arterial hypertension.
    JCI Insight. 2026;11:e194613.
    PubMed         Abstract available
    
    

    
    Life Sci

67. SOARES LL, Leite LB, Ervilha LOG, Pelozin BRA, et al
    Resistance exercise training benefits pulmonary, cardiac, and muscular structure and function in rats with stable pulmonary artery hypertension.
    Life Sci. 2023;332:122128.
    PubMed         Abstract available
    
    

    
    Magn Reson Med

68. GARCIA DELGADO GM, Shammi UA, Thornburgh C, Ruppel M, et al
    Dynamic RBC-To-Membrane Ratio in (129)Xe MRI: A Biomarker of Decreased Lung Function in Pulmonary and Vascular Diseases.
    Magn Reson Med. 2026;95:2500-2507.
    PubMed         Abstract available
    
    

    
    Neoreviews

69. NEVAREZ GILBERT AB, Bischoff AR
    Pulmonary Hypertension in Infants Who Are Premature.
    Neoreviews. 2026;27:e144-e156.
    PubMed         Abstract available
    
    

    
    NPJ Cardiovasc Health

70. MAN HJ, Zhao YD, Asghar U, Wu L, et al
    Distinct endothelial cells in chronic thromboembolic pulmonary hypertension.
    NPJ Cardiovasc Health. 2025;2:33.
    PubMed         Abstract available
    
    

    
    Pain Manag

71. MOUSTAFA M, Gopal H, Minnock C, Gaine S, et al
    Rectus sheath block a retrospective review of a novel adjunct for treatment of the injection site pain associated with treprostinil subcutaneous infusion in pulmonary hypertension case series.
    Pain Manag. 2026 Mar 9:1-7. doi: 10.1080/17581869.2026.2641557.
    PubMed         Abstract available
    
    

    
    Pediatr Res

72. GILLEY J, Shivanna B
    The relationship between cobalamin C deficiency and unexplained pediatric pulmonary hypertension.
    Pediatr Res. 2026 Mar 3. doi: 10.1038/s41390-026-04899.
    PubMed        
    
    

    
    Physiol Rep

73. LI X, Mao Z, Wang C, Liu Y, et al
    Intervention effect of small extracellular vesicles derived from dental pulp stem cells on a high-altitude pulmonary edema model in male rats.
    Physiol Rep. 2026;14:e70810.
    PubMed         Abstract available
    
    
74. KEMPTON H, Olsen N, Kearney K, Hayward CS, et al
    The resistance-compliance relationship at low pulmonary resistance: Integrating pulmonary wedge pressure into right ventricular load assessment.
    Physiol Rep. 2026;14:e70811.
    PubMed         Abstract available
    
    
75. ZEIDAN EM, Nagarajan SA, Sydykov A, Bier J, et al
    The effect of mitoTEMPO on the development of hypoxia-induced pulmonary hypertension in male mice.
    Physiol Rep. 2026;14:e70804.
    PubMed         Abstract available
    
    

    
    Physiol Res

76. YANG MX, Wu ZZ, Wu DW, Chen MH, et al
    Role of PKM2 Tetramer in Modulating Endothelial Mitochondrial Dysfunction in a Rat Model of Chronic Thromboembolic Pulmonary Hypertension.
    Physiol Res. 2026;75:45-53.
    PubMed         Abstract available
    
    

    
    PLoS One

77. CALE R, Ferreira F, Martinho M, Alegria S, et al
    Residual physiological abnormalities after pulmonary endarterectomy and balloon pulmonary angioplasty in CTEPH.
    PLoS One. 2026;21:e0344192.
    PubMed         Abstract available
    
    
78. KAWAKAMI T, Hosokawa S, Ito M, Kurozumi A, et al
    PAH-former: Transfer learning for efficient discovery of pulmonary arterial hypertension-associated genes.
    PLoS One. 2026;21:e0344084.
    PubMed         Abstract available
    
    

    
    Pulm Circ

79. BUNCLARK K, Newman J, Ghani H, Munagala S, et al
    The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3.
    Pulm Circ. 2026;16:e70256.
    PubMed         Abstract available
    
    
80. QUYAM S, Drumm S, Mungala S, Bunclark K, et al
    The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70269.
    PubMed         Abstract available
    
    
81. TARRAS ES, Murayama A, Singh I, Freeman LM, et al
    Industry Payments and Prescribing Patterns of Pulmonary Hypertension Therapies in the United States.
    Pulm Circ. 2026;16:e70279.
    PubMed         Abstract available
    
    
82. LACHANT D, Agarwal N, Norton K, Haight D, et al
    Longitudinal Remote 6-Minute Walk Distance and Cardiac Effort Using Wearable Sensors in Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70278.
    PubMed         Abstract available
    
    
83. BUNCLARK K, Newman J, Ghani H, Munagala S, et al
    The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life.
    Pulm Circ. 2026;16:e70264.
    PubMed         Abstract available
    
    
84. LIU BY, Yan WJ, Chen Y, Zhang HW, et al
    The Prognostic Accuracy of Three-Dimensional Echocardiography in Patients With Pre-Capillary Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70260.
    PubMed         Abstract available
    
    

    
    Pulm Pharmacol Ther

85. WU SE, Mazurek JA, Mayeux JD, Habib NG, et al
    Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH).
    Pulm Pharmacol Ther. 2026;92:102406.
    PubMed         Abstract available
    
    

    
    Pulmonology

86. KHILZI K, Blanco I, Piccari L, Barbera JA, et al
    Smoking exposure on diagnosis and survival of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from REHAP registry.
    Pulmonology. 2026;32:2640669.
    PubMed         Abstract available
    
    

    
    Respir Med

87. PANG L, Du S, Wu S, Xian Q, et al
    Genetic assessment of the causal relationship between obstructive sleep apnea and pulmonary hypertension: Mendelian randomization and meta-analysis.
    Respir Med. 2026;255:108760.
    PubMed         Abstract available
    
    
88. RESQUETI V, Torres-Castro R, Gimeno-Santos E, Lopes Cardoso N, et al
    Limitations of 6-minute walk test-based equations in predicting peak oxygen uptake and risk assessment in patients with pulmonary hypertension and COPD.
    Respir Med. 2026;254:108738.
    PubMed         Abstract available
    
    

    
    Respir Med Case Rep

89. MIRDAMADI A, Adib-Hajbagheri P
    Misleading echocardiographic artifact mimicking severe pulmonary hypertension in a pregnant woman: A diagnostic challenge.
    Respir Med Case Rep. 2026;60:102374.
    PubMed         Abstract available
    
    

    
    Respir Res

90. CHEN R, Liu C, Han J, Dong J, et al
    Paradigm shift: from pulmonary vasodilation to cardiopulmonary dual-track therapy-a comprehensive review of pathophysiology and advances in pulmonary hypertension-associated right heart failure.
    Respir Res. 2026 Mar 7. doi: 10.1186/s12931-026-03594.
    PubMed        
    
    

    
    Respirol Case Rep

91. MUNOZ-BONET JI, Sebastian-Cuevas FJ, Flor-Macian EM, Ortega-Sanchez MDC, et al
    Hypercapnia as a Key Mechanism in the Development of Pulmonary Hypertension in Malignant Pertussis: A Case Report.
    Respirol Case Rep. 2026;14:e70528.
    PubMed         Abstract available
    
    

    
    Sci Prog

92. WANG Y, Shen R, Liu Y
    Impact of pulmonary-artery-to-aorta ratio on clinical outcomes in patients undergoing transcatheter aortic valve implantation: A retrospective study.
    Sci Prog. 2026;109:368504261431852.
    PubMed         Abstract available
    
    

    
    Ulus Travma Acil Cerrahi Derg

93. KARACA BAYSAL P, Urkut N, Girgin Dinc E, Gurcu ME, et al
    Emergency cesarean section in pregnant women with severe pulmonary hypertension: the potential role of extracorporeal life support.
    Ulus Travma Acil Cerrahi Derg. 2026;32:177-183.
    PubMed         Abstract available
    
    

    
    Vascul Pharmacol

94. D'ALTO M, Scelsi L, Giuliani L, Perna GP, et al
    Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO).
    Vascul Pharmacol. 2026;162:107585.
    PubMed         Abstract available
    
    
95. MANZI G, Maggio E, Recchioni T, Adamo FI, et al
    The pleiotropic effects of sotatercept.
    Vascul Pharmacol. 2026;162:107577.
    PubMed         Abstract available
    
    

    
    Zhongguo Zhong Yao Za Zhi

96. ZHENG RX, Wang SZ, Tan JL, Cao XY, et al
    [Junren Bufei Yixin Granules attenuates hypoxic pulmonary hypertension via PTBP1/PKM2 signaling pathway].
    Zhongguo Zhong Yao Za Zhi. 2026;51:543-552.
    PubMed         Abstract available
    
    
97. TONG XL, Zhang L, Zhu J, Tong JB, et al
    [Mechanisms of Qibai Pingfei Capsules in inhibiting pyroptosis of pulmonaryartery adventitial fibroblasts via regulating NLRP3/Caspase-1/ GSDMD pathway to intervene in COPD complicated by pulmonary arterial hypertension].
    Zhongguo Zhong Yao Za Zhi. 2025;50:6892-6900.
    PubMed         Abstract available
    
    

    
    Zhonghua Jie He He Hu Xi Za Zhi

98. CHEN J, Zhang ZL, Chen YY, Ren JH, et al
    [Use of modified balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension: a retrospective study from a single center].
    Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:317-323.
    PubMed         Abstract available
    
    
99. HUANG Q, Xiong CM, Wang JZ, Zhai ZG, et al
    [Enhancing the capacity of pulmonary vascular intervention system in China: current status, opportunities, and challenges].
    Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:251-256.
    PubMed         Abstract available
    
    
100. GUO WL, Hou P, Tan WG, Lei YX, et al
     [A case of metastatic breast cancer complicated by pulmonary tumor thrombotic microangiopathy].
     Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1014-1018.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum